IFN-γ/Doxorubicin Complex Nanoparticles for Enhancing Therapy in the Context of Human Ovarian Carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IFN-γ/Doxorubicin Complex Nanoparticles for Enhancing Therapy in the Context of Human Ovarian Carcinoma
Authors
Keywords
-
Journal
Frontiers in Materials
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-25
DOI
10.3389/fmats.2022.944930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
- (2022) Rony Abdi Syahputra et al. MOLECULES
- Advanced drug delivery system against ischemic stroke
- (2022) Shanshan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Dually acid- and GSH-triggered bis(β-cyclodextrin) as drugs delivery nanoplatform for effective anticancer monotherapy
- (2021) Jian Chen et al. NANOTECHNOLOGY
- Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy
- (2021) Zhongying Gong et al. ACS Applied Materials & Interfaces
- Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways
- (2021) Leonie Schürmann et al. CANCER LETTERS
- Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine
- (2020) María Pulido et al. Cancers
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin
- (2019) Parisa Yousefpour et al. Small
- Low doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblasts
- (2019) V. Quagliariello et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice
- (2019) Yao Xu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IFN-γ-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair
- (2019) José R. García et al. BIOMATERIALS
- Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity
- (2018) Curtis J. Perry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Co-delivery of Doxorubicin and Interferon-gamma by Thermosensitive Nanoparticles for Cancer Immunochemotherapy
- (2018) Yijia Yin et al. MOLECULAR PHARMACEUTICS
- C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease
- (2018) Antoine Dufour et al. Nature Communications
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies
- (2016) Salyan Bhattarai et al. JOURNAL OF AUTOIMMUNITY
- SENP1 regulates IFN-γ−STAT1 signaling through STAT3−SOCS3 negative feedback loop
- (2016) Tingting Yu et al. Journal of Molecular Cell Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search